Cargando…

Decreased Efficiency of Very-Low-Density Lipoprotein Lipolysis Is Linked to Both Hypertriglyceridemia and Hypercholesterolemia, but It Can Be Counteracted by High-Density Lipoprotein

Impaired triglyceride-rich lipoprotein plasma catabolism is considered the most important factor for hypertriglyceridemia development. The aim of this study was to evaluate the impact of hypercholesterolemia and hypertriglyceridemia on the efficiency of lipoprotein lipase (LPL)-mediated very-low-den...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wieczorek, Ewa, Ćwiklińska, Agnieszka, Kuchta, Agnieszka, Kortas-Stempak, Barbara, Gliwińska, Anna, Jankowski, Maciej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068045/ https://www.ncbi.nlm.nih.gov/pubmed/33917704 http://dx.doi.org/10.3390/nu13041224

Ejemplares similares

The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism
por: Wieczorek, Ewa, et al.
Publicado: (2021)

The Impact of Lipoprotein Apheresis on Oxidative Stress Biomarkers and High-Density Lipoprotein Subfractions
por: Mickiewicz, Agnieszka, et al.
Publicado: (2020)

Detection of Lipoprotein X (LpX): A challenge in patients with severe hypercholesterolaemia
por: Ćwiklińska, Agnieszka, et al.
Publicado: (2020)

Changes in the size and electrophoretic mobility of HDL subpopulation particles in chronic kidney disease
por: Gliwińska, Anna, et al.
Publicado: (2022)

Interaction Between VLDL and Phosphatidylcholine Liposomes Generates New γ-LpE-like Particles
por: Ćwiklińska, Agnieszka, et al.
Publicado: (2013)

The effect of Cistus incanus herbal tea supplementation on oxidative stress markers and lipid profile in healthy adults
por: Kuchta, Agnieszka, et al.
Publicado: (2021)

PON-1 Activity and Plasma 8-Isoprostane Concentration in Patients with Angiographically Proven Coronary Artery Disease
por: Kuchta, Agnieszka, et al.
Publicado: (2016)

Plasma Levels of Preβ1-HDL Are Significantly Elevated in Non-Dialyzed Patients with Advanced Stages of Chronic Kidney Disease
por: Kuchta, Agnieszka, et al.
Publicado: (2019)

The results of external quality assessment programme on urine leukocyte and erythrocyte counting in Poland
por: Ćwiklińska, Agnieszka, et al.
Publicado: (2020)

Apolipoprotein E gene polymorphism and renal function are associated with apolipoprotein E concentration in patients with chronic kidney disease
por: Czaplińska, Monika, et al.
Publicado: (2019)

Impaired Very‐Low‐Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia
por: Hoogerland, Joanne A., et al.
Publicado: (2021)

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein
Publicado: (1982)

Modulation of adipose tissue lipolysis and body weight by high-density lipoproteins in mice
por: Wei, H, et al.
Publicado: (2014)

Nordic walking training attenuation of oxidative stress in association with a drop in body iron stores in elderly women
por: Kortas, Jakub, et al.
Publicado: (2017)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Lipoprotein(a) As a Potential Predictive Factor for Earlier Aortic Valve Replacement in Patients with Bicuspid Aortic Valve
por: Krzesińska, Aleksandra, et al.
Publicado: (2023)

Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor
por: Lede, Vera, et al.
Publicado: (2016)

Role of glycosylphosphatidylinositol‐anchored high‐density lipoprotein binding protein 1 in hypertriglyceridemia and diabetes
por: Kurooka, Naoko, et al.
Publicado: (2023)

Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
por: Fahed, Akl C., et al.
Publicado: (2012)

Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
por: Wang, Anthony, et al.
Publicado: (2016)

Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia
por: Chan, Melody Lok-Yi, et al.
Publicado: (2022)

Does low-density lipoprotein fully explain atherosclerotic risk in familial hypercholesterolemia?
por: Clarke, Shoa L.
Publicado: (2023)

Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDL
por: Schekatolina, Svetlana, et al.
Publicado: (2022)

Accuracy of low-density lipoprotein cholesterol estimation at very low levels
por: Quispe, Renato, et al.
Publicado: (2017)

Higher Responsiveness to Rosuvastatin in Polygenic versus Monogenic Hypercholesterolemia: A Propensity Score Analysis
por: Mickiewicz, Agnieszka, et al.
Publicado: (2020)

Hypercholesterolemia, low density lipoprotein receptor and proprotein convertase subtilisin/kexin-type 9
por: Gu, Hong-mei, et al.
Publicado: (2015)

Familial hypercholesterolemia class II low-density lipoprotein receptor response to statin treatment
por: Omer, Linda, et al.
Publicado: (2020)

Differing Nutrient Intake and Dietary Patterns According to the Presence of Hyper-Low-Density Lipoprotein Cholesterolemia or Hypertriglyceridemia
por: Kwon, Yu-Jin, et al.
Publicado: (2021)

Impact of Pemafibrate Therapy on Reducing Small Dense Low-Density-Lipoprotein-Cholesterol Levels in Patients with Hypertriglyceridemia
por: Hida, Yuki, et al.
Publicado: (2023)

The association of very-low-density lipoprotein with ankle-brachial index in peritoneal dialysis patients with controlled serum low-density lipoprotein cholesterol level
por: Kanda, Eiichiro, et al.
Publicado: (2013)

Association of Genetically Enhanced Lipoprotein Lipase–Mediated Lipolysis and Low-Density Lipoprotein Cholesterol–Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes
por: Lotta, Luca A., et al.
Publicado: (2018)

Very-Low-Density Lipoprotein: Complex Particles in Cardiac Energy Metabolism
por: Niu, You-Guo, et al.
Publicado: (2011)

Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL)
por: Huang, Jih-Kai, et al.
Publicado: (2022)

High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes
por: Androulakis, Emmanuel, et al.
Publicado: (2017)

Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia
por: Trinder, Mark, et al.
Publicado: (2020)

Analysis of the low density lipoprotein receptor gene (LDLR) mutation spectrum in Russian familial hypercholesterolemia
por: Vasilyev, V.B., et al.
Publicado: (2022)

Low-density lipoprotein receptor genotypes modify the sera metabolome of patients with homozygous familial hypercholesterolemia
por: Du, Zhiyong, et al.
Publicado: (2022)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

Lipoprotein metabolism in familial hypercholesterolemia
por: Chemello, Kévin, et al.
Publicado: (2021)

Lipoprotein Lipase and PPAR Alpha Gene Polymorphisms, Increased Very-Low-Density Lipoprotein Levels, and Decreased High-Density Lipoprotein Levels as Risk Markers for the Development of Visceral Leishmaniasis by Leishmania infantum
por: Carvalho, Márcia Dias Teixeira, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5sarda4rnln1i0p8m8cr8okcvo